KIF5C基因突变导致神经发育障碍研究进展

陈亦儒, 陈文雄

中国儿童保健杂志 ›› 2023, Vol. 31 ›› Issue (2) : 171-175.

PDF(837 KB)
PDF(837 KB)
中国儿童保健杂志 ›› 2023, Vol. 31 ›› Issue (2) : 171-175. DOI: 10.11852/zgetbjzz2022-0476
综述

KIF5C基因突变导致神经发育障碍研究进展

  • 陈亦儒, 陈文雄
作者信息 +

Research progress in neurodevelopmental disorder caused by KIF5C gene mutation

  • CHEN Yi-ru, CHEN Wen-xiong
Author information +
文章历史 +

摘要

KIF5C基因是神经发育障碍如孤独症的相关候选基因。KIF5C基因编码KIF5C驱动蛋白,帮助沿微管长距离顺行运送神经突成熟所需要货物,对神经元发育重要。驱动蛋白包括头部马达结构域、茎部二聚化结构域、及尾部结构域。头部马达结构域外显子区是基因突变常见区域,偶见内含子突变报道;c.709G>A是热点突变位点,造成p.Glu237Lys氨基酸突变。KIF5C基因突变造成儿童常见神经发育障碍包括皮质发育畸形、小头畸形、癫痫、发育迟缓/智力障碍,及孤独症样特征等;KIF5C基因突变造成相关障碍的机制尚未明了,可能通过影响马达结构域水解ATP能力;深入研究致病机制及寻找新的疾病治疗靶标重要;KIF5C基因治疗有待进一步研究。

Abstract

KIF5C gene is the candidate gene of neurodevelopmental disorder such as autism spectrum disorder(ASD). KIF5C gene encodes KIF5C kinesin, which helps to transport cargos required for neurite maturation along microtubules for a long distance, and is important for neuronal development. The structure of KIF5C kinesin includes the head motor domain, stalk dimerization domain and tail domain. The exonic region of head motor domain is a common region of gene mutation, and intron mutation is occasionally reported. The c.709G>A is a hot spot mutation site, causing p.glu237lys amino acid mutation. KIF5C gene mutation causes the common neurodevelopment disorder in children, including malformation of cortical dysplasia (MCD), microcephaly, epilepsy, development delay/intellectual disability, autism-like features and so on. The mechanism of neurodevelopmental disorder caused by KIF5C gene mutation is not clear yet,but it might affect the ability of head motor domain to hydrolyze ATP. It is important to study the pathogenic mechanism of KIF5C gene mutation and its novel therapeutic interventions in depth. KIF5C gene therapy needs further study.

关键词

KIF5C基因 / 基因突变 / 驱动蛋白 / 神经发育障碍 / 儿童

Key words

KIF5C gene / gene mutation / kinesin / neurodevelopment disorder / children

引用本文

导出引用
陈亦儒, 陈文雄. KIF5C基因突变导致神经发育障碍研究进展[J]. 中国儿童保健杂志. 2023, 31(2): 171-175 https://doi.org/10.11852/zgetbjzz2022-0476
CHEN Yi-ru, CHEN Wen-xiong. Research progress in neurodevelopmental disorder caused by KIF5C gene mutation[J]. Chinese Journal of Child Health Care. 2023, 31(2): 171-175 https://doi.org/10.11852/zgetbjzz2022-0476
中图分类号: R749.94   

参考文献

[1] American Psychiatric Association. The diagnostic and statistical manual of mental disorders[M].5th ed.Washington DC:American Psychiatric Publishing Inc,2013.
[2] Kodak T, Bergmann S. Autism spectrum disorder:Characteristics, associated behaviors, and early Intervention[J]. Pediatr Clin North Am, 2020, 67(3):525-535.
[3] Liu X, Zou M, Sun C, et al. Prenatal folic acid supplements and offspring′s autism spectrum disorder:A meta-analysis and meta-regression[J]. J Autism Dev Disord, 2022, 52(2):522-539.
[4] Bai D, Yip BHK, Windham GC, et al. Association of genetic and environmental factors with autism in a 5-country cohort[J]. JAMA Psychiatry, 2019, 76(10):1035-1043.
[5] Robinson EB, Samocha KE, Kosmicki JA, et al. Autism spectrum disorder severity reflects the average contribution of de novo and familial influences[J]. Proc Natl Acad Sci USA, 2014, 111(42):15161-15165.
[6] Yuen RK, Thiruvahindrapuram B, Merico D, et al. Whole-genome sequencing of quartet families with autism spectrum disorder[J]. Nat Med, 2015, 21(2):185-191.
[7] Willsey HR, Willsey AJ, Wang B, et al. Genomics, convergent neuroscience and progress in understanding autism spectrum disorder[J]. Nat Rev Neurosci, 2022, 23(6):323-341.
[8] Wu J, Yu P, Jin X, et al. Genomic landscapes of Chinese sporadic autism spectrum disorders revealed by whole-genome sequencing[J]. J Genet Genomics, 2018, 45(10):527-538.
[9] Coe BP, Stessman HAF, Sulovari A, et al. Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity[J]. Nat Genet, 2019, 51(1):106-116.
[10] Kanai Y, Okada Y, Tanaka Y, et al. KIF5C, a novel neuronal kinesin enriched in motor neurons[J]. J Neurosci, 2000, 20(17):6374-6384.
[11] Vale RD, Reese TS, Sheetz MP. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility[J]. Cell, 1985, 42(1):39-50.
[12] Hirokawa N, Noda Y. Intracellular transport and kinesin superfamily proteins, KIFs:Structure, function, and dynamics[J]. Physiol Rev, 2008, 88(3):1089-1118.
[13] Woehlke G, Schliwa M. Walking on two heads:The many talents of kinesin[J]. Nat Rev Mol Cell Biol, 2000, 1(1):50-58.
[14] Hirokawa N, Noda Y, Tanaka Y, et al. Kinesin superfamily motor proteins and intracellular transport[J]. Nat Rev Mol Cell Biol, 2009, 10(10):682-696.
[15] Klinman E, Holzbaur ELF. Walking forward with kinesin[J]. Trends Neurosci, 2018, 41(9):555-556.
[16] Twelvetrees AE, Pernigo S, Sanger A, et al. The dynamic localization of cytoplasmic dynein in neurons is driven by kinesin-1[J]. Neuron, 2016, 90(5):1000-1015.
[17] Nakajima K, Yin X, Takei Y, et al. Molecular motor KIF5A is essential for GABA(A) receptor transport, and KIF5A deletion causes epilepsy[J]. Neuron, 2012, 76(5):945-961.
[18] Fukuda Y, Pazyra-murphy MF, Silagi ES, et al. Binding and transport of SFPQ-RNA granules by KIF5A/KLC1 motors promotes axon survival[J]. J Cell Biol, 2021, 220(1):e202005051.
[19] Zhao J, Fok AHK, Fan R, et al. Specific depletion of the motor protein KIF5B leads to deficits in dendritic transport, synaptic plasticity and memory[J]. Elife, 2020, 9:e53456.
[20] Cho KI, Cai Y, Yi H, et al. Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function[J]. Traffic, 2007, 8(12):1722-1735.
[21] Iworima DG, Pasqualotto BA, Rintoul GL. Kif5 regulates mitochondrial movement, morphology, function and neuronal survival[J]. Mol Cell Neurosci, 2016, 72:22-33.
[22] Campbell PD, Shen K, Sapio MR, et al. Unique function of Kinesin Kif5A in localization of mitochondria in axons[J]. J Neurosci, 2014, 34(44):14717-14732.
[23] Hares K, Kemp K, Loveless S, et al. KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis[J]. J Neurol, 2021, 268(6):2175-2184.
[24] Citrigno L, Magariello A, Pugliese P, et al. Kinesins in neurological inherited diseases:a novel motor-domain mutation in KIF5A gene in a patient from Southern Italy affected by hereditary spastic paraplegia[J]. Acta Neurol Belg, 2018, 118(4):643-646.
[25] Poirier K, Lebrun N, Broix L, et al. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly[J]. Nat Genet, 2013, 45(6):639-647.
[26] Cavallin M, Hubert L, Cantagrel V, et al. Recurrent KIF5C mutation leading to frontal pachygyria without microcephaly[J]. Neurogenetics, 2016, 17(1):79-82.
[27] Willemsen MH, Ba W, Wissink-lindhout WM, et al. Involvement of the kinesin family members KIF4A and KIF5C in intellectual disability and synaptic function[J]. J Med Genet, 2014, 51(7):487-494.
[28] Morita H, Komuro I. Somatic mutations in cerebral cortical malformations[J]. N Engl J Med, 2014, 371(21):2037.
[29] Michels S, Foss K, Park K, et al. Mutations of KIF5C cause a neurodevelopmental disorder of infantile-onset epilepsy, absent language, and distinctive malformations of cortical development[J]. Am J Med Genet A, 2017, 173(12):3127-3131.
[30] Al-shamsi A, Hertecant JL, Souid AK, et al. Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates[J]. Orphanet J Rare Dis, 2016, 11(1):94.
[31] Duquesne S, Nassogne MC, Clapuyt P, et al. Phenotype description in KIF5C gene hot-spot mutations responsible for malformations of cortical development (MCD)[J]. Eur J Med Genet, 2020, 63(9):103991.
[32] Turner TJ, Zourray C, Schorge S, et al. Recent advances in gene therapy for neurodevelopmental disorders with epilepsy[J]. J Neurochem, 2021, 157(2):229-262.
[33] Benger M, Kinali M, Mazarakis ND. Autism spectrum disorder:Prospects for treatment using gene therapy[J]. Mol Autism, 2018, 9:39.

基金

广州市重点领域研发计划 “脑科学与类脑研究重大科技专项” (202007030002);广州市科技计划项目 (202102010232)。

PDF(837 KB)

Accesses

Citation

Detail

段落导航
相关文章

/